COVID-19 — Worldwide/Unknown
Background: Recent data suggest that complications and death from coronavirus disease 2019 (COVID-19) may be related to high viral loads.
Methods: In this ongoing, double-blind, phase 1-3 trial involving nonhospitalized patients with COVID-19, we investigated 2 fully human, neutralizing monoclonal antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein, used in a combined cocktail (REGN-COV2) to reduce the risk of the emergence of treatment-resistant
…
